Waters Unveils New Line of Calorimeters, New Solid-Core Column Chemistries and More
Complete the form below to unlock access to ALL audio articles.
Waters Corporation has unveiled its new line of differential scanning calorimeters reaffirming TA Instruments' position as the technology and global leader in thermal analysis at the 2016 Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy. Additionally, the company highlighted new CORTECS® column chemistries and reported that its GlycoWorks™ RapiFluor-MS™ N-Glycan Kit has already saved biopharmaceutical laboratories industry-wide approximately four years of work based on sales in just its first year of availability.
"Innovation is the engine that drives Waters," said Christopher J. O'Connell, President and CEO of Waters Corporation. "From the days of Jim Waters, our commitment to innovation has been deeply engrained in the organization's makeup. For decades, the organization's central focus has been to innovate and push the boundaries of analytical science to develop and support the technologies that enable our customers around the globe to be successful. Seeing the comprehensive product portfolio from Waters and TA Instruments here at Pittcon underscores the company's innovation leadership."
Three New Discovery DSC systems
The new line of Differential Scanning Calorimeters, the Discovery DSC 2500, DSC 250, and DSC 25 feature enhanced sensing technologies resulting in unprecedented performance in baseline flatness, sensitivity, resolution, and reproducibility.
At the core of every new Discovery DSC is the exclusive TA Fusion Cell™, which incorporates design concepts that “fuse” together features of the Q-Series and first generation Discovery DSC, patented Tzero® technology, and new proprietary manufacturing processes. Additionally, an app-style user interface is standard with each new model and combined with powerful new TRIOS software, automated calibration and verification routines work seamlessly to dramatically improve laboratory work-flows and productivity.
The Discovery DSC measures the change in energy in a sample as the temperature is raised or lowered. It is used for a wide range of applications, including material science, pharmaceuticals, chemistry and studies of biomaterials. It excels in both research environments and production control processes.
“DSC is the anchor of a thermal analysis laboratory," said Terry Kelly, President of TA Instruments. "In terms of performance and ease-of-use the new Discovery Series DSC is so advanced, that upgrading to one of our powerful new systems will bring scientists lasting benefits.”
The DSC 2500 comes standard with all options, which includes the all-new linear autosampler that allows for enhanced flexibility in assigning sample and reference pans to any combination of the available 54 positions and TA’s exclusive T4P heat flow technology. We believe that it is the only DSC on the market capable of making and storing heat capacity measurements in a single run.
The DSC 250 is a flexible and configurable research-grade DSC that includes Tzero technology, and is well-equipped to satisfy the most demanding researcher. The DSC 25 is a cost-effective, easy to use, general purpose DSC with performance superior to competitive research grade systems. It is ideal for research, teaching, and quality control laboratories that require a rugged, reliable, basic DSC.
GlycoWorks Saves Industry Nearly Four Years of Work
Emphasizing the impact of its innovations, Waters revealed that its GlycoWorks RapiFluor-MS N-Glycan Kit has already saved biopharmaceutical laboratories industry wide approximately four years of work in just its first year of availability.
These calculations are based on purchases by all 15 top revenue generating pharmaceutical companies and 90% of the top biopharmaceutical companies with glycoproteins in their pipeline.
Most biotherapeutic proteins available on the market today are glycoproteins. The heterogeneous glycan populations on these proteins are critical quality attributes that affect potency, stability, and therapeutic safety profiles. As a result, biopharmaceutical companies must provide detailed structural information pertaining to the glycans attached to their biotherapeutics when submitting new applications to regulatory authorities and on an ongoing basis throughout the manufacturing process. Waters estimates about 4.4 million released glycan analyses are performed per year, and that number is growing at double digit rates.
A ground-breaking technology for characterizing glycoproteins, the GlycoWorks RapiFluor-MS N-Glycan Kit combined with Waters' ACQUITY UPLC® System, the ACQUITY UPLC FLR Detector and the ACQUITY® QDa® Detector, and enables scientists to analyze released N-glycans and achieve new levels of speed, sensitivity, simplicity while obtaining previously unattainable structural information.
Expansion of CORTECS Solid-Core LC Columns
Waters today added to its CORTECS® Columns product family with the introduction of two new LC column chemistries. Built on Waters proven solid-core particle technology, the Waters® CORTECS C8 and CORTECS Phenyl analytical columns are designed for scientists who need to expand their chromatographic separation space while maximizing the speed, resolution and sensitivity of their small molecule HPLC, UHPLC or UPLC® separations. Capable of operating at very high column efficiencies and low backpressures, the new columns give scientists additional selectivity choices and allow them to develop methods quickly, and generate more information with every analytical run. The CORTECS C8 and CORTECS Phenyl chemistries are available in two particle sizes, 1.6 and 2.7 micron, and are offered in a total of 50 unique column configurations.
CORTECS C8 Columns exhibit a lower hydrophobicity when compared to typical bonded C18 phases and are useful for separating strongly hydrophobic compounds.
They are also ideal for chemists looking to transfer or scale compendial C8 HPLC methods to a more robust column technology.
CORTECS Phenyl Columns are an excellent alternative to typically bonded C18 phases, particularly for aromatic compounds, based on the unique selectivity provided by the Phenyl bonded phase.